DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Anti-inflammatory Therapeutics Market 2017-2021" report to their offering.
Thee global anti-inflammatory therapeutics market to grow at a CAGR of 6.10% during the period 2017-2021.
Global Anti-Inflammatory therapeutics market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market. To calculate the market size, the report considers sales of branded, off-label, and generic drugs.
One trend in the market is emergence of novel anti-inflammatory drugs. Cytokines are proteins produced by immune cells. These protein molecules facilitate communication between cells and play a pivotal role in cell development and differentiation including regulation of immune response.
According to the report, one driver in the market is availability of targeted therapy. The global anti-inflammatory therapeutics market is no stranger to biologics. The biologics are macromolecules, consisting of genetically engineered protein derived from living cells. As biologics can be produced by using DNA recombinant technology, they offer targeted therapy and can also be modified depending on patient's need. Owing to their benefits over other small molecules, biologics are dominating the global anti-inflammatory therapeutics market with more than 60% of market share in 2016.
- Johnson & Johnson
Other prominent vendors:
- Boehringer Ingelheim
- Eli Lilly
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Inflammation: An overview
Part 06: Market landscape
Part 07: Key clinical trial
Part 08: Market segmentation by application
Part 09: Market segmentation by drug class
Part 10: Geographical segmentation
Part 11: Decision framework
Part 12: Drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
Part 16: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/x8fsfb/global